Current news of SHS and our portfolio companies
More patient safety with simulators for cardiologists – SHS invests 10 million euro in Swiss Simulands AG
SHS invests €10 million euro from its newly launched sixth fund generation into the Zurich-based growth company Simulands AG develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions The investment aims to further accelerate the commercialisation of the company and help revolutionise cardiovascular education and training through advanced training solutions for physicians […]
Cautious growth: SHS Medical Technology Index grows slightly in second year of Corona crisis
Medical technology market in Germany with slight growth in 2021 Pandemic leaves positive as well as negative traces on medical technology companies in second year, with the former predominating SHS expects a good development for medical technology in Germany in 2022 due to the improvement in the pandemic situation The new regulatory requirements (MDR/IVDR) will […]
As this year’s SHS annual project, we are pleased to support the inclusion football team “Tübingen United” with our annual donation
On the initiative of Elisa Mayer and Tomma Hinke, two football clubs, SSC Tübingen and SV Bühl, have launched an inclusive training format. This means that children and young people with disabilities who are interested in football now have the opportunity to pursue their hobby in the club. Since May 2022, children, youths and young […]
MEDTECH-INSIDE – Part 18: The MDR: a brake block from Brussels
The European Medical Device Regulation (MDR), whose goals were initially supported by the European medtech industry, has been in force since May 2022. After half a year, the situation for the medium-sized medtech industry is devastating.
SHS sells shares in endoscope manufacturer Blazejewski MEDI-TECH GmbH to Erbe Group
Blazejewski MEDI-TECH GmbH is one of the technology leaders in the field of complex 2D and 3D endoscopy and has been able to grow very strongly in recent years Reinhold Blazejewski, Founder and Managing Director of Blazejewski MEDI-TECH, also sells part of his shares to the Erbe Group, but remains with the company as a […]
(No) end to the Corona crisis: Is it still worth investing in healthcare now?
At the beginning of the Corona pandemic, many market participants were looking for investment opportunities in the health market. Companies like BioNTech, which had previously remained niche, became stock market stars. Can investors also profit from the transition to endemicity?
MEDTECH-INSIDE – Part 17: Financing in Medtech SMEs
Medium-sized medical technology companies are facing many challenges in these geopolitically turbulent times: Supply chain problems, the MDR medical device regulation, digitalisation, energy shortages and rising refinancing costs due to the jump in interest rates. It’s good to have a solid capital base.
SHS appoints Manfred Ulmer-Weber to the Management Board
Tübingen / 18.08.2022 Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft für Beteiligungsmanagement mbH. Ulmer-Weber will be jointly responsible for the allocation of the new SHS VI fund of the Tübingen-based sector specialist. The additional Managing Partner is an SHS home-grown and started his career at SHS in 2010. The shareholders […]
More than 220 million euros for growth and succession investments in European healthcare companies. SHS launches sixth fund generation and exceeds target volume already in first closing
SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over 220 million euros for its sixth fund at the first closing. Faster than expected, the Tübingen-based healthcare investor has already exceeded its target of 200 million euros at the first closing. The sixth SHS fund generation also aims at majority and minority investments in the […]
MEDTECH-INSIDE – Part 16: Germany leads in DiGA
Digital health applications (DiGA) can improve medical care.